ARCHIVES

In Phase II Study, NKTR-102 Shows Objective Response

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Flow Lab Lands Top Virology Contract – $1.9 Mil.

February 21, 1975

Rogers Subcommittee Rewrite Cancer Control Definition, Adds $45 Million Over Three Years

April 21, 1978

Breast Cancer Progress Report Summaries

November 14, 1975

UICC Fellowship, Exchange Programs

July 5, 1985

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

Centers Structures, Governance, Funding, Review considered By NCI, NCAB, Center Directors

September 30, 1977